N/A N=81 Diagnostic

Home Versus Ambulatory Monitoring, Diurnal Blood Pressure Profile, Detection of Non-Dippers

Hypertension

Bottom Line

View on ClinicalTrials.gov: NCT01460732 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2012

Primary outcome: Primary: Awake Systolic Home Blood Pressure Measurement — 131.5 mmHg

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Blood Pressure Monitoring (Device)
Age: Adult, Older Adult · 30+ yrs
Sex: All
Sponsor: University of Athens
Primary completion: Dec 2011

Outcome Measures

Outcome	Result	p-value
PRIMARY Awake Systolic Home Blood Pressure Measurement	131.5	—
PRIMARY Awake Diastolic Home Blood Pressure Measurement	79.9	—
PRIMARY Asleep Systolic Home Blood Pressure Measurement	114.8	—
PRIMARY Asleep Diastolic Home Blood Pressure Measurement	66.6	—
PRIMARY Awake Systolic Ambulatory Blood Pressure Measurement	130.0	—
PRIMARY Awake Diastolic Ambulatory Blood Pressure Measurement	81.0	—
PRIMARY Asleep Systolic Ambulatory Blood Pressure Measurement	115.2	—
PRIMARY Asleep Diastolic Ambulatory Blood Pressure Measurement	67.6	—
SECONDARY Dippers Defined by ABPM and HBPM-Nocturnal	84; 78	—

Summary

This is a cross-sectional study, including adults, either untreated for hypertension, or under stable treatment for more than four weeks. Assessment will include: Clinic blood pressure measurements with an automated oscillometric device, 24-hour ambulatory blood pressure monitoring Home blood pressure monitoring during morning, evening and nocturnal measurements with the same device.

Eligibility Criteria

Inclusion Criteria:ma

Patients referred for high blood pressure
Age over 30 years
Untreated for hypertension or under stable treatment for 4 weeks or more
Patients physically and mentally capable for self-measurement of blood pressure at home
Written informed consent to participate in the study

Exclusion Criteria

Sustained arrythmia
Pregnancy
Symptomatic cardiovascular disease
Any other serious disease (renal failure, heart failure, malignancy)

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01460732). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.